An impact of air pollution on moderate to severe relapses among multiple sclerosis patients

Miri Elgabsi1, Lena Novack2, Shaked Yarza3

  • 1Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Abstract

Insights

Exposure to particulate matter (PM) and nitrogen dioxide (NO2) is linked to increased Multiple Sclerosis (MS) relapses. This study highlights environmental factors impacting MS disease activity, particularly in non-smokers and younger individuals.

Area of Science:

  • Environmental Health
  • Neurology
  • Epidemiology

Background:

  • Multiple Sclerosis (MS) is a chronic central nervous system inflammatory disease with genetic and environmental influences.
  • Understanding environmental triggers for MS relapses is crucial for disease management.

Purpose of the Study:

  • To investigate the association between exposure to specific air pollutants and meteorological factors and the incidence of moderate to severe MS relapses.
  • To analyze these associations using both semi-ecological and case-crossover epidemiological approaches.

Main Methods:

  • A cohort of 287 MS patients in Southern Israel (2000-2017) was studied.
  • Exposure to PM2.5, PM10, NO2, SO2, and O3 was assessed using satellite-based models and monitoring stations.
  • Time-series and case-crossover analyses were employed, adjusting for relevant covariates.

Main Results:

  • Particulate matter (PM2.5) showed an independent association with MS relapses in non-smokers (RR=1.28).
  • Ozone (O3) was linked to increased relapses in patients under 40 (RR=1.58).
  • Elevated PM10 and NO2 levels were associated with relapses across all subjects (OR=1.05 and OR=1.85, respectively).

Conclusions:

  • Ambient exposure to particulate matter (PM) and nitrogen dioxide (NO2) is adversely associated with MS relapses.
  • These findings underscore the role of air pollution as an environmental risk factor in MS exacerbations.

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
898
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
504